Loading clinical trials...
Loading clinical trials...
Predicting Length of Mechanical Ventilation in Moderate-to-severe Acute Respiratory Distress Syndrome Using Machine Learning
The investigators are planning to perform a secondary analysis of an academic dataset of 1,303 patients with moderate-to-severe acute respiratory distress syndrome (ARDS) included in several published cohorts (NCT00736892, NCT022288949, NCT02836444, NCT03145974), aimed to characterize the best early scenario during the first three days of diagnosis to predict duration of mechanical ventilation in the intensive care unit (ICU) using supervised machine learning (ML) approaches.
The acute respiratory distress syndrome (ARDS) is an important cause of morbidity, mortality, and costs in intensive care units (ICUs) worldwide. Most ARDS patients require mechanical ventilation (MV). Few studies have investigated the prediction of MV duration of ARDS. For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented \[Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
No
Hospital Universitario Dr. Negrin
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Universitario Puerta de Hierro (ICU)
Majadahonda, Madrid, Spain
Hospital Universitario NS de Candelaria
Santa Cruz de Tenerife, Tenerife, Spain
Hospital NS del Prado
Talavera de la Reina, Toledo, Spain
Hospital Universitario de A Coruña (ICU)
A Coruña, Spain
Complejo Hospitalario Universitario de Albacete (ICU)
Albacete, Spain
Complejo Hospitalario de Albacete
Albacete, Spain
Department of Anesthesia, Hospital Clinic
Barcelona, Spain
Hospital General de Ciudad Real (ICU)
Ciudad Real, Spain
Hospital Virgen de La Luz
Cuenca, Spain
Start Date
August 14, 2023
Primary Completion Date
February 2, 2024
Completion Date
February 2, 2024
Last Updated
March 20, 2024
1,303
ACTUAL participants
Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
OTHER
Lead Sponsor
Dr. Negrin University Hospital
Collaborators
NCT07450846
NCT07414056
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06701669